The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...

Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell ...

The antiretroviral drug has been hailed as a potential game-changer in the fight against HIV, with early trials finding the treatment 100 percent effective in preventing HIV infection. With ...

Biktarvy is a complete treatment for HIV, which means that you don’t need to take any other drugs with it. Biktarvy is meant to be used as a long-term treatment. If you and your doctor determine ...

The agreement also covers lenacapavir as a treatment of HIV ... drug is approved for multi-drug resistant HIV and sold under the brand "Sunlenca" for an annual list price of $42,250 per year.